World Orphan Drug Congress USA 2017
community download

[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

Medicines for rare diseases accounted for 41% of new FDA-approved drugs in 2016.   However, developing new treatments for orphan indications is hugely challenging.


Two of the greatest difficulties consist of finding and recruiting enough subjects to support statistically valid clinical trials and properly and ethically caring for trial patients suffering the quality-of-life (QoL) issues these diseases engender. In this whitepaper, Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies, Tom Ruane, Senior Director, Patient Recruitment PAREXEL discusses how to challenge conventional patient recruitment methods and care strategies to successfully recruit patients for these important studies.


Download this whitepaper for insight on:

  • How conventions can get in the way
  • Patient-first trial design
  • Leveraging technology for the benefit of patients and clinicians

 

 

 

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*
Company:*
Industry:
Country:*

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details


Privacy statement »
Manage your email preferences »
 

You will be emailed the document as an attachment (230Kb in size)